Senate Finance Committee member Rob Portman (R-OH) on Thursday (Feb. 4) formally announced his opposition to the Trans-Pacific Partnership (TPP) "in its current form," citing dissatisfaction with the deal's terms on market exclusivity for biologic drugs, among other concerns. "I am disappointed that the President made the decision to have Ambassador Froman sign the TPP agreement in New Zealand. From currency manipulation, to rules of origin for automobiles, to protection for U.S. biologics -- we can do better," Portman said...